The Solution is Cathaid™
Cathaid™ seamlessly replaces the flawed standard of care with one simple to use device. Cathaid™ gives clinicians the ability to detect positional shifts, secure the catheter, and provides a full medical seal around the entry site. These all act to safeguard the patient while adding fidelity to high risk medical catheters. The patented ability to detect positional shifts is a market first capability. Cathaid™ is poised to replace a clumsy standard of care that simply does not provide adequate protections for medical catheters.
Cathaid™ can also be manufactured to accommodate the differing types of catheters available on the market. This allows for flexibility in how Cathaid™ can be applied in differing medical fields while maintaining its designed functionality.
Cathaid's Positional Verification System allows clinicians the ability to detect dangerous positional shifts without using radio-graphic methods. Health care providers of all levels can easily detect changes through the easy to use positional indicator.
Cathaid's antimicrobial adhesive film technology can be tailored to the clinicians' specification. Antimicrobial protection can range from basic Chlorhexidine impregnation for low risk usage to multi-substance, multi-organism protection for high risk medical catheters.
By applying Cathaid to a medical catheter, a clinician can be assured that optimal positioning will be held during the lifetime of catheter usage. Cathaid's securement mechanism locks the catheter securely between the foundation cover and base with a strong layer of medical grade adhesive. The strength of adhesive can be varied according to clinical usage (high vs low tension situation).
Easy to Installation and Removal
Medical catheters are invaluable tools in modern medicine and their usage extends into almost every aspect of modern medicine. Each year, over 300 million medical catheters are used around the world. While they are a invaluable tool for doctors, their use is not without risks. Catheter associated infections and inadvertent positional shifts are a major source of morbidity and mortality for patients.
Even with the standard of care using up to four products to protect the catheter, 25% of catheters will experience a failure due to infection and other complications. Additionally, health care providers are unable to assess positional changes without utilizing radio-graphic imaging. This exposes the patient to unnecessary radiation and is financially costly for the healthcare system.
MEET OUR TEAM
Served as the COO for the startup Intent Solutions, creator of the breakthrough medical device technology tad™.
Successful exit from a healthcare technology firm he Co-founded (Innovative Product Achievements) who was a market leader in dispensing and retrieval systems for hospital suits and linens.
BA and MS in Mechanical Engineering and MBA from Georgia Institute of Technology.
George Hsu, MD
More than 9 years of experience caring for critically ill children; has first-hand knowledge of how technology and innovation can save lives
Georgia Tech: Bachelors, Biology. Georgia State: Masters, Cellular and and Molecular Biology. Mercer: MD. Medical College of Georgia: Residency & Fellowship
Published scientific articles pertaining to critical care, pediatrics, and resuscitation
Xiaoyu Alan Zheng, MS
Mechanical Engineer at the National Institute of Standards and Technology (NIST)
Over 10 years experience in mechanical engineering with extensive experience in CAD design, 3D printing, and prototyping
University of Maryland (BC): Bachelors, Mechanical Engineering. Johns Hopkins: Masters, Mechanical Engineering with a focus on manufacturing and rapid prototyping
Published over 25 articles in scientific research journals
CEO of NFANT Labs, a medical device company that transforms a baby bottle into a smart device which measures infant tongue movement
Medical Device Executive with 30+ years of experience in commercialization, R&D, manufacturing, supply chain, and regulatory
Veteran of start-up & growth stage medical device companies
Acquisition and rollup expert
John W. Richards, Jr., MD, MMM, CPE
Serial entrepreneur of over 30 companies
Pioneered concepts & products in pharma, HC delivery, HC technology, health promotion, disease prevention & management, cost containment, managed care & disaster mgmt.
Built one of the first mail order pharmacies (FPA), and the first AIDS Medication Program (Buyer's Clubs), specialty injectable programs (JITI), physician-office dispensing (DRx) and national home infusion (FBHS) companies.
Manufacturing: Cathaid™ has contracted a major US converter to begin production of the first batch of Cathaids™ for pilot testing.
Pilot Test: Cathaid™ officially partnered with Augusta University to bring a safer standard of care for all medical catheters.
Commercialization: Upon completion of the pilot test, Cathaid™ aims to be fully commercialized by the end of 2020.
Staff: John W. Richards, Jr., MD, MMM, CPE, a pioneer of medical innovations and serial entrepreneur, joins the Cathaid™ team. He brings with him over 25 years of experience and knowledge.
Cathaid™ establishes office in the medical district of Augusta, GA.